Search

everythinglearnresearchcommunity

for

Search:↓

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Candida antigen is an effective and promising treatment for alopecia areata.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

IL-10 may worsen alopecia areata instead of helping it.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.